In October 2025, the State Council officially issued the "Regulations on the Administration of Clinical Research and Clinical Translation Application of New Biomedical Technologies," which accelerated the development of the cell and gene therapy field. It clarified the access boundaries and division of labor among clinical institutions, research universities, and enterprises under the "dual-track" approach, improved the level of technical standards, and accelerated the drug innovation process. This is not only a milestone in industry standardization but also a golden window of opportunity for industrial collaboration.
The 15th Cell Biology Industry Conference and the 6th International Conference and Exhibition on Cell Therapy and Regenerative Medicine (Chengdu Station) will be held in Chengdu, China, from March 5-6, 2026. On May 15, 2025, the "Several Measures of Sichuan Province to Promote the Development of the Pharmaceutical and Health Industry" were issued, which explicitly stated:Expand the number of medical institutions piloting stem cell clinical research and support collaboration between enterprises and medical institutions to develop cell and gene therapy products.This follows the release in February of the "Guidelines for the Filing of Stem Cell Clinical Research Institutions and Projects in Sichuan Province (Trial Implementation)," making it the fourth...This is an important manifestation of Sichuan Province's continued efforts in the two billion-yuan sectors of cell drugs and cell therapy.
Everyone300+ will be invitedSeveral experts and scholars from renowned hospitals, pharmaceutical companies, and leading biotechnology companies both domestically and internationally discussed stem cells, anti-aging, and regenerative medicine.The event explored and implemented cutting-edge technologies such as chemistry, cell therapy, exosomes, and gene therapy, showcasing advancements in drug development, CMC (Clinical Management), and clinical trials.Exciting content including applications, process optimization, quality control, and industrial investment will help promote the cell biology industry and the field of regenerative medicine.Innovation and development and the transformation of research results.